Bone Neoplasms Clinical Trial
Official title:
Malignant Pediatric Soft Tissue & Bone Tumors of the Extremities: A Retrospective Study
Verified date | January 2020 |
Source | Assiut University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim of this study is to identify demographic & disease characteristics in pediatric oncology patients diagnosed with soft tissue & bone tumors involving the extremities & treatment outcomes in these patients.
Status | Completed |
Enrollment | 163 |
Est. completion date | December 2019 |
Est. primary completion date | November 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 18 Years |
Eligibility |
Inclusion Criteria: - Patients whose age less than 19 years. - Patients diagnosed with bone & soft tissue neoplasms involving the extremities. Exclusion Criteria: - Patients whose age more than 19 years. - Patients diagnosed with bone & soft tissue neoplasms not involving the extremities. |
Country | Name | City | State |
---|---|---|---|
Egypt | Assiut University | Assiut |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Egypt,
Bakotic BW, Borkowski P. Primary soft-tissue neoplasms of the foot: the clinicopathologic features of 401 cases. J Foot Ankle Surg. 2001 Jan-Feb;40(1):28-35. Review. — View Citation
Cormier JN, Pollock RE. Soft tissue sarcomas. CA Cancer J Clin. 2004 Mar-Apr;54(2):94-109. Review. — View Citation
Sondak VK. Difficult situations in sarcoma. Issue 2. Surg Oncol. 2000 Aug;9(2):47. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Overall survival (OS) | Time from the date of initiation of treatment until death from any cause | Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years | |
Primary | Event Free Survival (EFS) | Time from the date of initiation of treatment until disease progression, or death for any reason. | Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02303366 -
Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475
|
Phase 1 | |
Withdrawn |
NCT00095017 -
Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)
|
Phase 2 | |
Withdrawn |
NCT00851162 -
Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions
|
Phase 2/Phase 3 | |
Completed |
NCT00168129 -
Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases
|
Phase 1 | |
Completed |
NCT04300179 -
Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt
|
||
Recruiting |
NCT02677961 -
An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
|
||
Completed |
NCT01479283 -
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)
|
Phase 3 | |
Completed |
NCT03839095 -
Localized Osteosarcoma in Upper Egypt: A Clinical Prediction Model
|
||
Recruiting |
NCT06335251 -
Radiotherapy Treatments for Neoplasms of the Limbs
|
||
Completed |
NCT00558272 -
Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease
|
Phase 2 | |
Completed |
NCT00211211 -
FREE Study - Fracture Reduction Evaluation
|
Phase 4 | |
Completed |
NCT02274623 -
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
|
Phase 1 | |
Completed |
NCT02107664 -
The Palliative Radiotherapy And Inflammation Study - PRAIS
|
||
Terminated |
NCT00381095 -
A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer
|
Phase 4 | |
Completed |
NCT00434447 -
Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases
|
Phase 4 | |
Completed |
NCT00909142 -
Bonefos and the Consumption of Analgesics
|
N/A |